CD274 and neoplasm: Currently, multiple ongoing clinical trials are exploring this,16 although in the KEYNOTE-017 trial, tumor viral or PD-L1 status was not associated with improved overall survival.25 This is in contrast to a study demonstrating that patients with positive MCPyV status were more likely to express PD-L1 and have improved overall survival.28